Results 141 to 150 of about 271,654 (205)

Anecdotal vs. evidence‐based, off label use of drug eluting stents for infrapopliteal disease: Abusus non tollit usum (Misuse does not nullify proper use) [PDF]

, 2007
Roger J. Laham
openalex   +1 more source

Pharmacogenomic testing for neuropsychiatric drugs: current status of drug labeling, guidelines for using genetic information, and test options. [PDF]

Pharmacotherapy, 2014
Drozda K, Müller DJ, Bishop JR.
europepmc   +1 more source

Corrigendum: Extracellular vesicles from human breast cancer-resistant cells promote acquired drug resistance and pro-inflammatory macrophage response. [PDF]

Front Immunol
Santos P, Rezende CP, Piraine R, Oliveira B, Ferreira FB, Carvalho VS, Calado RT, Pellegrini M, Almeida F.   +8 more
europepmc   +1 more source

Audit experiences in investigational medicinal product management and errors in clinical trials. [PDF]

Trials
Kim Y, Lee H.
europepmc   +1 more source

Animal Experimentation and the Labelling of Drugs [PDF]

Alternatives to Laboratory Animals, 2011
openaire   +3 more sources

Impact of pharmacometrics on drug approval and labeling decisions: A survey of 42 new drug applications

, 2005
Venkatesh Atul Bhattaram, Brian Booth, Roshni Ramchandani, B. Nhi Beasley, Yaning Wang, Veneeta Tandon, John Duan, Raman Baweja, Patrick Marroum, Ramana Uppoor, Nam Atiqur Rahman, Chandrahas G. Sahajwalla, J. Robert Powell, Mehul U. Mehta, Jogarao Gobburu   +14 more
openalex   +2 more sources

Improving drug repositioning with negative data labeling using large language models. [PDF]

J Cheminform
Picard M, Leclercq M, Bodein A, Scott-Boyer MP, Perin O, Droit A.   +5 more
europepmc   +1 more source

Labelling of dispensed drugs

Sri Lanka Journal of Child Health, 2009
openaire   +3 more sources